Table 2 Meta-analysis of the association of childhood leukemia with different types of vaccines from fourteen included studies.

From: Early vaccination protects against childhood leukemia: A systematic review and meta-analysis

Type of vaccines

No. of study

Total sample size (Leukemia/Control)

Heterogeneity

Model

Association with leukemia

Egger’s 2-tailed bias p-value

p-value

I 2

p-value

Odds ratio (95% CI)

Early vaccination

7

3000/3719581

0.0001

77.9

Random

0.019

0.58 (0.36–0.91)

0.60

BCG vaccines

12

3778/3760815

0.0001

77.7

Random

0.117

0.73 (0.50–1.08)

0.47

Mumps vaccines

4

3431/4999

0.98

0

Fixed

0.95

1.01 (0.82–1.23)

0.54

Hib vaccines

3

2528/4004

0.001

84.6

Random

0.83

1.06 (0.64–1.76)

0.89

HBV vaccines

5

2266/3906

0.67

0

Fixed

0.95

1.00 (0.85–1.18)

0.69

Triple vaccines

4

1986/2714

0.2

35.1

Fixed

0.56

1.10 (0.79–1.53)

0.99

Poliosip vaccines

4

2390/2769

0.99

0

Fixed

0.93

0.98 (0.70–1.39)

0.29

MMR vaccines

4

2302/2667

0.98

0

Fixed

0.78

0.96 (0.75–1.24)

0.85

Measles vaccines

6

3715/5627

0.02

59.1

Random

0.81

1.02 (0.85–1.23)

0.23

Rubella vaccines

5

3548/5267

0.96

0

Fixed

0.98

1.00 (0.82–1.23)

0.10

  1. IPooled odds ratios (OR) with corresponding 95% confidence intervals (95% CI) of the pooled results were calculated where more than one study had investigated the factor.